News & Events

American College of Cardiology's (ACC) 58th Scientific Session

HCRI is committed to keeping our colleague's legacy alive by establishing the Penny Timbie Charitable Foundation at HCRI

Practical Clinical Electrophysiology provides a comprehensive and clinically based approach to the diagnosis and management of arrhythmia disorders for the cardiology fellow and practicing general cardiologist. The clinical approach encompasses evidence-based medicine as well as practical pearls for the diagnosis and management of arrhythmia disorders. Chapters provide a comprehensive discussion of arrhythmia disorders, from noninvasive diagnostic strategies through pharmacologic and invasive therapeutic strategies. The level of sophistication ranges from the most basic to more sophisticated topics, and provides an excellent complement to Josephson's more advanced text. See amazon.com link below for purchasing details.

The Harvard Clinical Research Institute (HCRI) announced today that Dr. Laura Mauri, M.D., M.Sc. will present the protocol for "The study of Dual Anti-Platelet Therapy (DAPT) at today's FDA Town Hall Sessions a the TCT Conference in Washington. The study is designed to help guide the global medical community to better understand the optimal duration of thienopyridine and aspirin in patients who undergo stenting procedures. Dr. Mauri is a cardiologist at the Brigham and Women's Hospital in Boston and the Chief Scientific Officer at the Harvard Clinical Research Institute (HCRI). Her slides will be made available on the HCRI web site .

Please visit HCRI at Booth #1536 in the Exhibition Hall.
Click on the image below to RSVP to the HCRI cocktail reception.

On June 26, HCRI was represented by 25 employees in the JP Morgan Corporate Challenge 3 mile race. The HCRI runners picked up 1st prize in the creative T-shirt Competition. HCRI announced that the $500 prize will be donated to the Cam Neely Foundation and HCRI will match with an additional $500. This year is the 4th year that HCRI has participated in the Corporate Challenge, and the company looks forward to success in 2009.

SAPPHIRE Three-Year Study Demonstrates Equivalent
Stroke and Repeat Procedure Outcomes